Wave Life Sciences Ltd (NASDAQ: WVE) has seen a rise in its stock price by 4.25 in relation to its previous close of 13.19. However, the company has experienced a 2.31% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-12-16 that CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 13, 2025, at 9:45 a.m. PT / 12:45 p.m. ET.
Is It Worth Investing in Wave Life Sciences Ltd (NASDAQ: WVE) Right Now?
Additionally, the 36-month beta value for WVE is -1.08. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for WVE is 117.59M and currently, short sellers hold a 5.89% ratio of that float. The average trading volume of WVE on December 20, 2024 was 1.96M shares.
WVE’s Market Performance
The stock of Wave Life Sciences Ltd (WVE) has seen a 2.31% increase in the past week, with a -3.58% drop in the past month, and a 157.49% gain in the past quarter. The volatility ratio for the week is 8.00%, and the volatility levels for the past 30 days are at 6.39% for WVE. The simple moving average for the last 20 days is -4.63% for WVE stock, with a simple moving average of 70.60% for the last 200 days.
Analysts’ Opinion of WVE
Many brokerage firms have already submitted their reports for WVE stocks, with Raymond James repeating the rating for WVE by listing it as a “Strong Buy.” The predicted price for WVE in the upcoming period, according to Raymond James is $22 based on the research report published on October 16, 2024 of the current year 2024.
JP Morgan, on the other hand, stated in their research note that they expect to see WVE reach a price target of $13, previously predicting the price at $10. The rating they have provided for WVE stocks is “Overweight” according to the report published on September 27th, 2024.
B. Riley Securities gave a rating of “Buy” to WVE, setting the target price at $11 in the report published on September 19th of the current year.
WVE Trading at -3.18% from the 50-Day Moving Average
After a stumble in the market that brought WVE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.84% of loss for the given period.
Volatility was left at 6.39%, however, over the last 30 days, the volatility rate increased by 8.00%, as shares sank -5.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +63.44% upper at present.
During the last 5 trading sessions, WVE rose by +0.45%, which changed the moving average for the period of 200-days by +97.95% in comparison to the 20-day moving average, which settled at $14.41. In addition, Wave Life Sciences Ltd saw 172.28% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at WVE starting from BOLNO PAUL, who sale 50,000 shares at the price of $15.00 back on Nov 25 ’24. After this action, BOLNO PAUL now owns 217,351 shares of Wave Life Sciences Ltd, valued at $750,000 using the latest closing price.
PAUL BOLNO, the Officer of Wave Life Sciences Ltd, proposed sale 50,000 shares at $15.00 during a trade that took place back on Nov 25 ’24, which means that PAUL BOLNO is holding shares at $750,000 based on the most recent closing price.
Stock Fundamentals for WVE
Current profitability levels for the company are sitting at:
- -2.84 for the present operating margin
- 0.17 for the gross margin
The net margin for Wave Life Sciences Ltd stands at -2.66. The total capital return value is set at -0.81. Equity return is now at value -243.82, with -51.04 for asset returns.
Currently, EBITDA for the company is -58.79 million with net debt to EBITDA at 1.98. When we switch over and look at the enterprise to sales, we see a ratio of 33.97. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.90.
Conclusion
In conclusion, Wave Life Sciences Ltd (WVE) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.